Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.35 trillion and total revenue of $115.79 billion.
Market Cap
1.35T
Revenue
115.79B
Profits
-38.76B
PE Ratio
n/a
Profit Margin
-33.48%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 134.67B | -2.71% | 184,643 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.44B | -1.46% | 101,263 | 15.53B |
| 3 | ARGX | argenx SE | 63.22B | -2.21% | 56,577 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 57.68B | -0.74% | 3,158,666 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 45.15B | 0.29% | 201,587 | - |
| 6 | ONC | BeOne Medicines AG | 39.35B | -3.41% | 70,479 | 6.13B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.39B | -0.62% | 502,377 | 4.80B |
| 8 | RPRX | Royalty Pharma plc | 34.49B | -6.21% | 1,885,494 | 2.54B |
| 9 | ROIV | Roivant Sciences Ltd. | 29.69B | 17.69% | 6,778,021 | 7.53M |
| 10 | INSM | Insmed Incorporated | 27.35B | -0.82% | 245,444 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.33B | -1.40% | 150,441 | 5.82B |
| 12 | BNTX | BioNTech SE | 25.18B | -3.39% | 236,390 | 3.03B |
| 13 | GMAB | Genmab A/S | 19.89B | -0.15% | 312,094 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.62B | -0.81% | 92,609 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.76B | -1.62% | 52,239 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.83B | 1.34% | 373,086 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 14.44B | -1.25% | 268,389 | 2.44B |
| 18 | SMMT | Summit Therapeutics Inc. | 13.88B | -1.16% | 1,316,368 | - |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.71B | -1.28% | 175,451 | 3.41B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.41B | -0.75% | 28,198 | 1.28B |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.19B | -2.50% | 241,194 | 1.66B |
| 22 | CORT | Corcept Therapeutics Incorporated | 12.17B | 0.85% | 107,177 | 830.81M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.15B | -0.37% | 229,695 | 669.50M |
| 24 | TECH | Bio-Techne Corporation | 11.35B | -0.09% | 559,043 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.94B | 1.05% | 54,375 | 776.57M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.66B | 5.45% | 638,306 | 67.67M |
| 27 | KRYS | Krystal Biotech, Inc. | 10.39B | -2.04% | 38,984 | 440.48M |
| 28 | ABVX | ABIVAX Société Anonyme | 9.93B | 1.33% | 504,479 | 5.67M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.84B | 0.80% | 100,178 | 105.00M |
| 30 | PRAX | Praxis Precision Medicines, Inc. | 9.83B | 0.12% | 63,086 | 7.46M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.40B | -0.28% | 69,284 | 281.99M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.22B | -4.48% | 3,867,182 | 874.09M |
| 33 | PCVX | Vaxcyte, Inc. | 9.00B | -1.08% | 259,923 | - |
| 34 | IBRX | ImmunityBio, Inc. | 8.70B | 1.61% | 1,757,225 | 165.79M |
| 35 | IMVT | Immunovant, Inc. | 8.25B | 1.76% | 194,990 | - |
| 36 | SYRE | Spyre Therapeutics, Inc. | 7.91B | 0.80% | 302,864 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 7.88B | -0.78% | 254,810 | 799.54M |
| 38 | BLTE | Belite Bio, Inc | 7.86B | 0.85% | 125,107 | - |
| 39 | CAI | Caris Life Sciences, Inc. | 7.17B | 1.20% | 1,162,677 | 989.61M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.04B | -0.53% | 73,250 | 239.92M |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.91B | 2.55% | 111,774 | - |
| 42 | CGON | CG Oncology, Inc. | 6.50B | -1.75% | 58,692 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.50B | -0.84% | 139,005 | 618.07M |
| 44 | ORKA | Oruka Therapeutics, Inc. | 6.23B | 1.65% | 129,353 | - |
| 45 | DNTH | Dianthus Therapeutics, Inc. | 6.14B | 1.53% | 75,093 | 1.90M |
| 46 | TVTX | Travere Therapeutics, Inc. | 6.06B | -1.59% | 279,662 | 591.33M |
| 47 | COGT | Cogent Biosciences, Inc. | 6.05B | 0.23% | 148,416 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.76B | -0.38% | 170,995 | 7.50M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.73B | -0.88% | 135,298 | 1.01B |
| 50 | ERAS | Erasca, Inc. | 5.67B | 0.12% | 246,347 | - |
| 51 | LGND | Ligand Pharmaceuticals Incorporated | 5.60B | -1.68% | 24,911 | 290.54M |
| 52 | CRSP | CRISPR Therapeutics AG | 5.24B | -2.80% | 466,539 | 13.39M |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.22B | 2.02% | 341,347 | - |
| 54 | PBLS | Parabilis Medicines, Inc. | 4.89B | -2.15% | 83,580 | 148.00K |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.81B | 2.76% | 214,307 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.80B | -0.50% | 179,127 | 1.14B |
| 57 | CELC | Celcuity Inc. | 4.75B | 1.40% | 77,175 | - |
| 58 | ELVN | Enliven Therapeutics, Inc. | 4.36B | 0.30% | 108,682 | - |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.16B | -0.32% | 365,952 | 10.35M |
| 60 | MANE | Veradermics, Incorporated | 4.15B | 0.74% | 86,570 | - |
| 61 | TLX | Telix Pharmaceuticals Limited | 4.05B | 1.51% | 103,380 | 890.79M |
| 62 | VKTX | Viking Therapeutics, Inc. | 4.01B | -1.38% | 364,292 | - |
| 63 | LEGN | Legend Biotech Corporation | 3.99B | -4.28% | 344,177 | 1.27B |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.95B | -0.91% | 113,216 | 606.33M |
| 65 | IOVA | Iovance Biotherapeutics, Inc. | 3.91B | -1.71% | 1,667,155 | 324.97M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.84B | 1.02% | 340,273 | 53.81M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.77B | -1.92% | 149,028 | 234.13M |
| 68 | ABCL | AbCellera Biologics Inc. | 3.74B | 1.05% | 791,147 | 66.17M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.69B | -2.23% | 102,773 | 117.00M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.52B | -1.17% | 416,032 | 3.60M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.51B | -22.69% | 4,633,873 | - |
| 72 | GPCR | Structure Therapeutics Inc. | 3.24B | -3.97% | 560,683 | - |
| 73 | CLDX | Celldex Therapeutics, Inc. | 3.12B | - | 76,606 | 158.00K |
| 74 | IMNM | Immunome, Inc. | 3.08B | 1.44% | 137,750 | 4.02M |
| 75 | QURE | uniQure N.V. | 3.05B | -1.19% | 100,664 | 18.67M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | 1.46% | 852,724 | 463.98M |
| 77 | MBX | MBX Biosciences, Inc. | 3.02B | 1.44% | 36,409 | - |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 3.01B | -0.79% | 991,338 | 7.12M |
| 79 | IRON | Disc Medicine, Inc. | 3.00B | -1.51% | 32,346 | - |
| 80 | ZLAB | Zai Lab Limited | 2.89B | -1.98% | 170,430 | 449.61M |
| 81 | SLS | SELLAS Life Sciences Group, Inc. | 2.86B | 2.09% | 1,698,963 | - |
| 82 | PHVS | Pharvaris N.V. | 2.84B | 14.72% | 2,548,716 | - |
| 83 | ATAI | AtaiBeckley Inc. | 2.73B | -0.34% | 5,213,540 | 4.47M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.69B | -0.84% | 561,113 | 36.77M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.64B | 5.85% | 274,493 | - |
| 86 | VRDN | Viridian Therapeutics, Inc. | 2.63B | 1.44% | 345,554 | 71.13M |
| 87 | NKTR | Nektar Therapeutics | 2.60B | 2.74% | 178,734 | 54.59M |
| 88 | BEAM | Beam Therapeutics Inc. | 2.57B | -13.28% | 2,448,883 | 156.04M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.54B | -1.98% | 118,508 | - |
| 90 | PGEN | Precigen, Inc. | 2.47B | -2.68% | 677,024 | 85.72M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.45B | -0.40% | 144,938 | 959.90M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.43B | -1.27% | 494,303 | - |
| 93 | OCUL | Ocular Therapeutix, Inc. | 2.38B | 1.74% | 193,617 | 52.06M |
| 94 | NUVB | Nuvation Bio Inc. | 2.33B | -2.35% | 449,361 | 169.90M |
| 95 | BHVN | Biohaven Ltd. | 2.28B | -3.76% | 955,640 | - |
| 96 | PVLA | Palvella Therapeutics, Inc. | 2.26B | -0.06% | 15,570 | - |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.19B | -0.26% | 32,504 | 20.00M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | 1.37% | 113,745 | 311.51M |
| 99 | KOD | Kodiak Sciences Inc. | 2.17B | -2.35% | 99,966 | - |
| 100 | ZBIO | Zenas BioPharma, Inc. | 2.15B | 0.40% | 46,730 | 1.00M |
| 101 | URGN | UroGen Pharma Ltd. | 2.15B | -0.18% | 69,689 | 188.73M |
| 102 | MESO | Mesoblast Limited | 2.15B | -4.45% | 22,702 | 120.25M |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | -10.36% | 1,350,581 | 1.97B |
| 104 | ADMA | ADMA Biologics, Inc. | 2.12B | -1.51% | 451,372 | 512.28M |
| 105 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | 0.52% | 51,949 | - |
| 106 | KLRA | Kailera Therapeutics, Inc. | 2.08B | -1.23% | 81,592 | - |
| 107 | GENB | Generate Biomedicines, Inc. | 2.06B | -2.07% | 288,177 | 26.48M |
| 108 | VCEL | Vericel Corporation | 2.03B | -1.27% | 45,024 | 306.30M |
| 109 | ZYME | Zymeworks Inc. | 2.01B | -2.84% | 60,873 | 37.13M |
| 110 | KARD | Kardigan, Inc. | 2.01B | 3.07% | 81,199 | - |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.97B | -0.27% | 76,188 | 98.34M |
| 112 | NBTX | Nanobiotix S.A. | 1.96B | -2.19% | 6,861 | 38.27M |
| 113 | STOK | Stoke Therapeutics, Inc. | 1.93B | 0.34% | 88,974 | 27.59M |
| 114 | GHRS | GH Research PLC | 1.89B | -2.44% | 38,616 | - |
| 115 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.88B | -0.96% | 337,183 | 208.78M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.88B | -3.31% | 4,521,930 | 54.86M |
| 117 | XNCR | Xencor, Inc. | 1.88B | -5.05% | 239,546 | 104.97M |
| 118 | VIR | Vir Biotechnology, Inc. | 1.86B | -3.21% | 243,923 | 303.23M |
| 119 | BRVE | Braveheart Bio, Inc. | 1.85B | 8.00% | 127,394 | - |
| 120 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -1.72% | 27,405 | 1.13B |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.82B | -2.16% | 97,938 | - |
| 122 | IMCR | Immunocore Holdings plc | 1.81B | -2.66% | 93,073 | 430.78M |
| 123 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | -1.75% | 153,857 | 252.25M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.80B | -1.52% | 223,360 | 5.49M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.77B | -1.10% | 1,639,294 | 59.51M |
| 126 | SEPN | Septerna, Inc. | 1.73B | 0.68% | 61,636 | 98.88M |
| 127 | TYRA | Tyra Biosciences, Inc. | 1.71B | -0.03% | 178,276 | - |
| 128 | ANAB | AnaptysBio, Inc. | 1.69B | 0.56% | 45,865 | 232.39M |
| 129 | AVLN | Avalyn Pharma Inc. | 1.67B | 0.95% | 30,147 | - |
| 130 | NVAX | Novavax, Inc. | 1.67B | -0.88% | 1,376,612 | 413.80M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.61B | -4.18% | 131,150 | 2.68B |
| 132 | AAPG | Ascentage Pharma Group International | 1.60B | -1.69% | 7,555 | 94.61M |
| 133 | LBRX | LB Pharmaceuticals Inc | 1.58B | -0.85% | 30,625 | - |
| 134 | APMD | Apnimed, Inc. | 1.55B | 1.82% | 60,108 | 120.15M |
| 135 | INVA | Innoviva, Inc. | 1.53B | -0.89% | 71,376 | 440.00M |
| 136 | ABSI | Absci Corporation | 1.52B | 0.57% | 576,762 | 1.56M |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.52B | -1.08% | 133,957 | - |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.51B | -0.81% | 118,307 | - |
| 139 | SLBT | SL Science Holding Limited | 1.51B | -7.99% | 44,488 | 3.27M |
| 140 | LTGO | Latigo Biotherapeutics, Inc. | 1.51B | -1.09% | 43,736 | - |
| 141 | VOR | Vor Biopharma Inc. | 1.51B | 1.68% | 207,569 | - |
| 142 | TRAX | First Tracks Biotherapeutics, Inc. | 1.49B | 2.90% | 52,209 | - |
| 143 | RARE | Ultragenyx Pharmaceutical Inc. | 1.47B | -2.35% | 1,407,926 | 717.00M |
| 144 | MAZE | Maze Therapeutics, Inc. | 1.46B | 0.06% | 30,342 | 20.00M |
| 145 | AKTS | Aktis Oncology, Inc. | 1.45B | -3.59% | 39,232 | 10.06M |
| 146 | INBX | Inhibrx Biosciences, Inc. | 1.44B | -19.46% | 604,975 | 1.30M |
| 147 | ALMS | Alumis Inc. | 1.42B | -1.35% | 520,350 | 7.40M |
| 148 | ANRO | Alto Neuroscience, Inc. | 1.41B | 1.35% | 105,106 | - |
| 149 | SVRA | Savara Inc. | 1.41B | 3.17% | 377,493 | - |
| 150 | REPL | Replimune Group, Inc. | 1.39B | -2.06% | 148,233 | - |
| 151 | CGEM | Cullinan Therapeutics, Inc. | 1.38B | -2.67% | 134,935 | - |
| 152 | MNKD | MannKind Corporation | 1.37B | 5.05% | 2,149,098 | 393.63M |
| 153 | OMER | Omeros Corporation | 1.37B | -0.32% | 125,292 | 38.42M |
| 154 | DRTS | Alpha Tau Medical Ltd. | 1.36B | -2.00% | 217,825 | - |
| 155 | SPTX | Seaport Therapeutics, Inc. | 1.33B | -0.40% | 51,379 | - |
| 156 | ODTX | Odyssey Therapeutics, Inc. | 1.32B | -3.86% | 29,477 | 99.00K |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 1.32B | -0.93% | 95,561 | - |
| 158 | MLTX | MoonLake Immunotherapeutics | 1.30B | 1.40% | 191,792 | - |
| 159 | IMTX | Immatics N.V. | 1.29B | -1.05% | 88,687 | 47.65M |
| 160 | MGTX | MeiraGTx Holdings plc | 1.29B | -3.24% | 82,789 | 397.50M |
| 161 | JBIO | Jade Biosciences, Inc. | 1.26B | -0.35% | 95,682 | - |
| 162 | JANX | Janux Therapeutics, Inc. | 1.23B | -0.84% | 74,150 | 24.00M |
| 163 | OBX | Obsidian Therapeutics, Inc. | 1.20B | 15.64% | 122,966 | - |
| 164 | GLUE | Monte Rosa Therapeutics, Inc. | 1.19B | 1.16% | 223,397 | 28.73M |
| 165 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -1.74% | 187,033 | - |
| 166 | ATTO | Attovia Therapeutics, Inc. | 1.17B | 0.23% | 73,898 | 1.80M |
| 167 | KURA | Kura Oncology, Inc. | 1.14B | -3.62% | 313,701 | 77.23M |
| 168 | SANA | Sana Biotechnology, Inc. | 1.13B | -1.56% | 564,190 | - |
| 169 | IVA | Inventiva S.A. | 1.10B | -1.26% | 383,876 | 7.94M |
| 170 | SLDB | Solid Biosciences Inc. | 1.07B | -2.59% | 126,377 | - |
| 171 | FTH | Faeth Therapeutics, Inc. | 1.06B | 1.97% | 52,927 | - |
| 172 | AVTX | Avalo Therapeutics, Inc. | 1.04B | 1.04% | 79,746 | 59.00K |
| 173 | ABUS | Arbutus Biopharma Corporation | 1.02B | 0.58% | 575,417 | 181.72M |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 987.80M | -0.89% | 303,757 | 41.47M |
| 175 | ANL | Adlai Nortye Group Ltd. | 978.20M | 1.20% | 59,250 | 18.06M |
| 176 | GERN | Geron Corporation | 973.35M | -3.50% | 1,675,343 | 204.56M |
| 177 | CADL | Candel Therapeutics, Inc. | 964.90M | -1.33% | 287,382 | - |
| 178 | SGP | SpyGlass Pharma, Inc. | 948.08M | -2.06% | 12,777 | - |
| 179 | WVE | Wave Life Sciences, Inc. | 946.82M | -1.13% | 667,698 | 65.37M |
| 180 | DSGN | Design Therapeutics, Inc. | 943.42M | -0.43% | 40,233 | - |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 942.35M | 0.19% | 124,160 | - |
| 182 | IMMX | Immix Biopharma, Inc. | 942.17M | -5.32% | 261,687 | - |
| 183 | ARDX | Ardelyx, Inc. | 926.98M | -1.59% | 462,095 | 450.89M |
| 184 | CLYM | Climb Bio, Inc. | 898.88M | 0.84% | 104,153 | - |
| 185 | HELP | Cybin Inc. | 896.08M | 0.37% | 570,976 | - |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 892.03M | -1.78% | 708,723 | 8.22M |
| 187 | ANNX | Annexon, Inc. | 891.97M | -3.39% | 341,771 | - |
| 188 | TBPH | Theravance Biopharma, Inc. | 886.25M | -0.06% | 63,024 | 104.31M |
| 189 | CBIO | Crescent Biopharma, Inc. | 884.70M | -1.01% | 33,564 | 11.88M |
| 190 | RIGL | Rigel Pharmaceuticals, Inc. | 879.73M | -3.24% | 34,167 | 276.79M |
| 191 | SLN | Silence Therapeutics plc | 853.17M | -2.88% | 427,761 | 615.00K |
| 192 | ACHV | Achieve Life Sciences, Inc. | 839.68M | -3.89% | 1,207,397 | - |
| 193 | FDMT | 4D Molecular Therapeutics, Inc. | 829.77M | 0.33% | 136,912 | 92.01M |
| 194 | PHAR | Pharming Group N.V. | 808.19M | 1.16% | 4,894 | 366.48M |
| 195 | DBVT | DBV Technologies S.A. | 800.35M | -1.34% | 85,334 | 5.04M |
| 196 | CTMX | CytomX Therapeutics, Inc. | 786.62M | -2.70% | 296,189 | 18.30M |
| 197 | MNPR | Monopar Therapeutics Inc. | 780.36M | -1.11% | 33,754 | - |
| 198 | AGMB | AgomAb Therapeutics NV | 778.12M | 0.13% | 117,659 | - |
| 199 | AURA | Aura Biosciences, Inc. | 771.56M | -1.59% | 106,681 | - |
| 200 | VSTM | Verastem, Inc. | 756.66M | 1.89% | 499,602 | 87.53M |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 755.36M | 2.58% | 160,258 | 136.07M |
| 202 | MPLT | MapLight Therapeutics, Inc. | 754.72M | -1.38% | 75,938 | - |
| 203 | NVCT | Nuvectis Pharma, Inc. | 753.77M | -5.53% | 42,985 | - |
| 204 | NGNE | Neurogene Inc. | 751.13M | -2.76% | 13,820 | 925.00K |
| 205 | OCS | Oculis Holding AG | 743.87M | -0.99% | 10,902 | 1.45M |
| 206 | GYRE | Gyre Therapeutics, Inc. | 740.12M | 1.75% | 66,202 | 109.82M |
| 207 | PHAT | Phathom Pharmaceuticals, Inc. | 739.49M | -2.00% | 260,659 | 239.66M |
| 208 | ASMB | Assembly Biosciences, Inc. | 727.18M | -2.42% | 18,788 | 74.85M |
| 209 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 725.58M | 0.78% | 9,812 | - |
| 210 | BLSM | BlossomHill Therapeutics, Inc. | 695.92M | 3.18% | 37,528 | - |
| 211 | SGMT | Sagimet Biosciences Inc. | 678.77M | -0.18% | 164,133 | - |
| 212 | STTK | Shattuck Labs, Inc. | 672.43M | -1.33% | 142,939 | 1.00M |
| 213 | MDXG | MiMedx Group, Inc. | 661.02M | -0.77% | 182,701 | 355.17M |
| 214 | ALT | Altimmune, Inc. | 659.42M | -0.88% | 1,052,625 | 31.00K |
| 215 | DRUG | Bright Minds Biosciences Inc. | 656.57M | 0.06% | 5,318 | - |
| 216 | ALLO | Allogene Therapeutics, Inc. | 654.71M | -3.81% | 1,268,417 | 4.64M |
| 217 | CRMD | CorMedix Inc. | 638.36M | -2.85% | 258,167 | 462.25M |
| 218 | VALN | Valneva SE | 637.30M | -1.31% | 10,661 | 163.30M |
| 219 | PRME | Prime Medicine, Inc. | 634.23M | -3.65% | 965,298 | 4.07M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 631.09M | 0.45% | 27,632 | - |
| 221 | PROK | ProKidney Corp. | 619.76M | 1.99% | 149,732 | 818.00K |
| 222 | OABI | OmniAb, Inc. | 617.18M | -1.96% | 238,913 | 38.46M |
| 223 | TECX | Tectonic Therapeutic, Inc. | 599.97M | -0.20% | 10,523 | - |
| 224 | ARVN | Arvinas, Inc. | 598.94M | -2.45% | 55,165 | 316.70M |
| 225 | ZURA | Zura Bio Limited | 593.18M | -0.64% | 273,906 | - |
| 226 | EIKN | Eikon Therapeutics, Inc. | 586.07M | -0.37% | 86,575 | - |
| 227 | AUTL | Autolus Therapeutics plc | 578.90M | -2.90% | 580,162 | 117.39M |
| 228 | RGNX | REGENXBIO Inc. | 576.96M | -2.24% | 164,404 | 174.48M |
| 229 | CABA | Cabaletta Bio, Inc. | 574.76M | -2.31% | 606,864 | - |
| 230 | SCTX | Scribe Therapeutics Inc. | 572.87M | 5.55% | 65,886 | 33.30M |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 554.49M | -0.83% | 83,693 | - |
| 232 | OVID | Ovid Therapeutics Inc. | 545.86M | -0.18% | 178,524 | 1.58M |
| 233 | PRLD | Prelude Therapeutics Incorporated | 543.81M | -3.30% | 43,711 | 22.42M |
| 234 | ARTV | Artiva Biotherapeutics, Inc. | 541.70M | -0.98% | 45,633 | 251.00K |
| 235 | SPRY | ARS Pharmaceuticals, Inc. | 533.04M | -4.63% | 242,240 | 116.93M |
| 236 | CAPR | Capricor Therapeutics, Inc. | 523.83M | -4.15% | 820,841 | 11.13M |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 499.70M | -2.06% | 113,519 | - |
| 238 | ENTX | Entera Bio Ltd. | 495.19M | -4.67% | 136,262 | 42.00K |
| 239 | PRTA | Prothena Corporation plc | 488.21M | -3.16% | 38,994 | 54.53M |
| 240 | EDIT | Editas Medicine, Inc. | 480.71M | -3.10% | 385,447 | 47.01M |
| 241 | PBYI | Puma Biotechnology, Inc. | 479.55M | -2.72% | 94,645 | 231.24M |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 466.39M | -0.26% | 18,696 | - |
| 243 | RZLT | Rezolute, Inc. | 465.92M | -2.62% | 105,723 | - |
| 244 | DNA | Ginkgo Bioworks Holdings, Inc. | 457.91M | -2.16% | 189,707 | 132.42M |
| 245 | IKT | Inhibikase Therapeutics, Inc. | 453.37M | -0.40% | 33,994 | 1.00 |
| 246 | RLMD | Relmada Therapeutics, Inc. | 453.35M | -4.06% | 424,695 | - |
| 247 | OCGN | Ocugen, Inc. | 452.71M | -1.84% | 656,470 | 4.58M |
| 248 | CCCC | C4 Therapeutics, Inc. | 449.04M | -2.93% | 770,306 | 35.04M |
| 249 | BNTC | Benitec Biopharma Inc. | 445.92M | 2.37% | 8,583 | - |
| 250 | EVMN | Evommune, Inc. | 443.85M | -0.33% | 47,070 | 10.00M |
| 251 | GALT | Galectin Therapeutics Inc. | 442.73M | -4.77% | 113,880 | - |
| 252 | ARCT | Arcturus Therapeutics Holdings Inc. | 432.31M | -3.86% | 132,061 | 29.37M |
| 253 | FENC | Fennec Pharmaceuticals Inc. | 431.85M | -0.61% | 31,745 | 59.22M |
| 254 | VOGX | Vogenx, Inc. | 431.51M | -2.28% | 15,530 | - |
| 255 | CMPX | Compass Therapeutics, Inc. | 413.30M | -3.57% | 331,276 | 850.00K |
| 256 | VTVT | vTv Therapeutics Inc. | 412.32M | -0.49% | 3,513 | 36.84M |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 410.56M | -3.11% | 136,758 | - |
| 258 | LRMR | Larimar Therapeutics, Inc. | 399.79M | - | 144,074 | - |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 399.60M | -2.56% | 13,149 | 65.26M |
| 260 | EYPT | EyePoint, Inc. | 393.56M | -0.33% | 494,361 | 2.79M |
| 261 | LXEO | Lexeo Therapeutics, Inc. | 392.98M | -2.04% | 40,757 | - |
| 262 | PALI | Palisade Bio, Inc. | 379.91M | 4.31% | 996,700 | 500.00K |
| 263 | ZNTL | Zentalis Pharmaceuticals, Inc. | 378.69M | 0.25% | 123,285 | 26.87M |
| 264 | IPSC | Century Therapeutics, Inc. | 373.02M | -2.37% | 62,300 | 109.16M |
| 265 | IRD | Opus Genetics, Inc. | 361.07M | -7.07% | 328,963 | 9.86M |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 355.37M | -2.37% | 25,233 | - |
| 267 | AGEN | Agenus Inc. | 350.93M | -5.40% | 287,930 | 132.69M |
| 268 | QTTB | Q32 Bio Inc. | 348.01M | -2.50% | 172,690 | 53.74M |
| 269 | ABEO | Abeona Therapeutics Inc. | 342.53M | -0.17% | 100,861 | 25.52M |
| 270 | LYEL | Lyell Immunopharma, Inc. | 340.87M | -3.20% | 9,231 | 27.00K |
| 271 | SABS | SAB Biotherapeutics, Inc. | 336.65M | -0.54% | 17,801 | 114.70K |
| 272 | PYXS | Pyxis Oncology, Inc. | 333.63M | 2.83% | 406,625 | 11.04M |
| 273 | XFOR | X4 Pharmaceuticals, Inc. | 332.14M | -17.08% | 435,687 | 15.85M |
| 274 | UPB | Upstream Bio, Inc. | 328.63M | -0.17% | 367,146 | 3.16M |
| 275 | VCRE | Vicore Pharma Holding AB (publ) | 322.90M | 2.29% | 1,277 | 412.09K |
| 276 | VNDA | Vanda Pharmaceuticals Inc. | 321.66M | -2.03% | 114,035 | 215.72M |
| 277 | IFRX | InflaRx N.V. | 320.53M | -2.03% | 102,130 | -11.54K |
| 278 | SION | Sionna Therapeutics, Inc. | 320.10M | -1.39% | 107,760 | - |
| 279 | STRO | Sutro Biopharma, Inc. | 317.86M | -4.48% | 18,480 | 45.70M |
| 280 | IMRX | Immuneering Corporation | 305.37M | -2.07% | 250,455 | - |
| 281 | TTRX | Turn Therapeutics Inc. | 301.16M | 3.16% | 25,683 | - |
| 282 | OBIO | Orchestra BioMed Holdings, Inc. | 295.12M | -3.35% | 78,387 | 31.98M |
| 283 | BCYC | Bicycle Therapeutics plc | 293.97M | -2.33% | 55,160 | 61.21M |
| 284 | CUVL | Clinuvel Pharmaceuticals Limited | 293.74M | -6.80% | 24,651 | 65.05M |
| 285 | FATE | Fate Therapeutics, Inc. | 293.56M | -1.21% | 243,904 | 6.49M |
| 286 | FULC | Fulcrum Therapeutics, Inc. | 292.22M | -0.52% | 156,433 | 80.00M |
| 287 | PRQR | ProQR Therapeutics N.V. | 289.30M | -0.97% | 187,609 | 21.05M |
| 288 | LCTX | Lineage Cell Therapeutics, Inc. | 284.52M | 4.17% | 789,433 | 13.08M |
| 289 | FHTX | Foghorn Therapeutics Inc. | 282.67M | -3.25% | 38,263 | 36.74M |
| 290 | ACIU | AC Immune SA | 277.90M | -2.27% | 34,837 | 21.67M |
| 291 | ALXO | ALX Oncology Holdings Inc. | 277.25M | -0.25% | 62,256 | - |
| 292 | CAMP | Camp4 Therapeutics Corporation | 274.23M | -0.91% | 10,024 | 4.22M |
| 293 | MGNX | MacroGenics, Inc. | 273.27M | -2.50% | 109,086 | 175.14M |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 269.88M | -3.78% | 11,692 | 1.48M |
| 295 | YDES | YD Bio Limited | 266.51M | 7.06% | 58,201 | 510.36K |
| 296 | ALEC | Alector, Inc. | 266.30M | -3.05% | 109,752 | 13.86M |
| 297 | SRZN | Surrozen, Inc. | 265.51M | -0.75% | 48,634 | 11.51M |
| 298 | AVXL | Anavex Life Sciences Corp. | 264.19M | -0.35% | 84,488 | - |
| 299 | TRDA | Entrada Therapeutics, Inc. | 263.58M | 2.52% | 82,357 | 4.69M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 257.68M | -1.74% | 27,154 | 7.15M |
| 301 | NAGE | Niagen Bioscience, Inc. | 246.60M | -1.89% | 58,303 | 129.08M |
| 302 | CLLS | Cellectis S.A. | 245.99M | -2.47% | 22,331 | 63.82M |
| 303 | CGEN | Compugen Ltd. | 245.34M | - | 39,043 | 74.00M |
| 304 | NGEN | NervGen Pharma Corp. | 244.61M | -2.36% | 176,558 | - |
| 305 | IVVD | Invivyd, Inc. | 243.71M | 0.10% | 720,940 | 58.37M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 239.96M | -2.32% | 181,151 | - |
| 307 | ADAG | Adagene Inc. | 236.34M | -1.68% | 8,132 | 9.29M |
| 308 | VRXA | Veraxa Biotech AG | 236.15M | -5.11% | 170,342 | 29.54K |
| 309 | NMRA | Neumora Therapeutics, Inc. | 235.81M | -4.20% | 100,413 | - |
| 310 | GLSI | Greenwich LifeSciences, Inc. | 231.92M | -0.94% | 10,304 | - |
| 311 | TARA | Protara Therapeutics, Inc. | 231.65M | -0.51% | 98,605 | - |
| 312 | ABOS | Acumen Pharmaceuticals, Inc. | 230.69M | 0.31% | 46,415 | - |
| 313 | SLGL | Sol-Gel Technologies Ltd. | 226.00M | -0.70% | 10,032 | 1.80M |
| 314 | ANTX | AN2 Therapeutics, Inc. | 222.08M | -0.08% | 40,060 | - |
| 315 | KROS | Keros Therapeutics, Inc. | 219.88M | -2.03% | 10,858 | 15.01M |
| 316 | TNXP | Tonix Pharmaceuticals Holding Corp. | 217.30M | -3.58% | 92,210 | 29.10M |
| 317 | RNA | Atrium Therapeutics, Inc. | 215.53M | -11.21% | 182,531 | 35.84M |
| 318 | ARMP | Armata Pharmaceuticals, Inc. | 214.91M | -1.03% | 1,912 | 5.54M |
| 319 | CHRS | Coherus Oncology, Inc. | 214.76M | -2.11% | 196,418 | 50.94M |
| 320 | PEPG | PepGen Inc. | 211.24M | -1.93% | 718,669 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 210.29M | -2.25% | 237,296 | 80.62M |
| 322 | VYGR | Voyager Therapeutics, Inc. | 210.12M | -2.85% | 65,515 | 34.46M |
| 323 | NBP | NovaBridge Biosciences | 208.80M | - | 28,880 | - |
| 324 | NERV | Minerva Neurosciences, Inc. | 208.66M | -1.35% | 11,449 | - |
| 325 | NKTX | Nkarta, Inc. | 208.43M | -0.34% | 122,448 | - |
| 326 | INDP | Indaptus Therapeutics, Inc. | 207.86M | 27.87% | 1,420,483 | - |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 205.49M | -1.40% | 35,965 | 2.00M |
| 328 | ACOG | Alpha Cognition Inc. | 204.71M | -1.26% | 37,108 | 15.26M |
| 329 | DTIL | Precision BioSciences, Inc. | 202.87M | -1.61% | 37,065 | 45.06M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 202.70M | -5.42% | 254,894 | - |
| 331 | CUE | Cue Biopharma, Inc. | 194.69M | -2.33% | 40,602 | 37.66M |
| 332 | MSLE | Satellos Bioscience Inc. | 190.92M | 2.79% | 28,163 | - |
| 333 | IPHA | Innate Pharma S.A. | 185.66M | -2.11% | 3,053 | 10.57M |
| 334 | CNTN | Canton Strategic Holdings, Inc. | 184.06M | 1.32% | 76,883 | 1.50M |
| 335 | KRRO | Korro Bio, Inc. | 181.42M | 0.65% | 13,727 | 2.38M |
| 336 | IMUX | Immunic, Inc. | 173.42M | -3.05% | 167,075 | - |
| 337 | MDWD | MediWound Ltd. | 172.93M | 0.79% | 43,862 | 11.86M |
| 338 | MENS | Jyong Biotech Ltd. | 172.22M | -2.93% | 13,216 | - |
| 339 | SPRB | Spruce Biosciences, Inc. | 169.85M | 2.02% | 54,180 | 697.00K |
| 340 | LENZ | LENZ Therapeutics, Inc. | 169.04M | -9.73% | 142,950 | 21.48M |
| 341 | KZIA | Kazia Therapeutics Limited | 168.28M | -0.24% | 40,747 | 1.27M |
| 342 | CRBU | Caribou Biosciences, Inc. | 166.17M | -1.27% | 205,666 | 10.04M |
| 343 | MIST | Milestone Pharmaceuticals Inc. | 164.87M | -2.50% | 352,687 | 2.34M |
| 344 | HUMA | Humacyte, Inc. | 163.93M | -2.45% | 520,388 | 2.12M |
| 345 | CDXS | Codexis, Inc. | 163.16M | 2.05% | 150,016 | 77.68M |
| 346 | OTLK | Outlook Therapeutics, Inc. | 159.43M | -1.74% | 933,245 | -1.16M |
| 347 | MOLN | Molecular Partners AG | 158.17M | - | 56 | 856.30K |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 155.73M | 1.65% | 377,609 | 1.34M |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 149.69M | -0.86% | 213,593 | 3.39M |
| 350 | INO | Inovio Pharmaceuticals, Inc. | 147.34M | -0.35% | 875,555 | 65.34K |
| 351 | EQ | Equillium, Inc. | 145.84M | 4.07% | 73,876 | 4.39M |
| 352 | BMEA | Biomea Fusion, Inc. | 144.24M | -1.97% | 907,583 | - |
| 353 | OKUR | OnKure Therapeutics, Inc. | 144.17M | -0.56% | 7,767 | - |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 142.62M | -0.78% | 316,130 | - |
| 355 | HURA | TuHURA Biosciences, Inc. | 132.62M | -2.76% | 107,694 | - |
| 356 | CNXU | Conexeu Sciences Inc. | 130.85M | -1.61% | 68,049 | - |
| 357 | ENGN | enGene Therapeutics Inc. | 129.29M | 6.04% | 319,103 | - |
| 358 | TLSA | Tiziana Life Sciences Ltd | 126.24M | -4.28% | 211,609 | - |
| 359 | VANI | Vivani Medical, Inc. | 125.38M | -6.71% | 112,700 | - |
| 360 | CBUS | Cibus, Inc. | 124.20M | 2.20% | 10,196 | 4.35M |
| 361 | RANI | Rani Therapeutics Holdings, Inc. | 122.90M | 1.90% | 122,109 | 4.88M |
| 362 | BDTX | Black Diamond Therapeutics, Inc. | 120.08M | -1.42% | 52,532 | 70.00M |
| 363 | TENX | Tenax Therapeutics, Inc. | 119.72M | 7.73% | 2,581,141 | - |
| 364 | NAUT | Nautilus Biotechnology, Inc. | 118.23M | 2.67% | 246,298 | 190.00K |
| 365 | CNTB | Connect Biopharma Holdings Limited | 117.13M | 1.09% | 308,825 | 2.95M |
| 366 | AARD | Aardvark Therapeutics, Inc. | 114.02M | -3.16% | 31,103 | - |
| 367 | GUTS | Fractyl Health, Inc. | 111.68M | 0.72% | 170,818 | 3.00K |
| 368 | COYA | Coya Therapeutics, Inc. | 111.66M | - | 35,909 | 8.02M |
| 369 | PMN | ProMIS Neurosciences, Inc. | 111.20M | -1.59% | 15,254 | - |
| 370 | ATRA | Atara Biotherapeutics, Inc. | 109.31M | 11.58% | 33,388 | 6.19M |
| 371 | SEER | Seer, Inc. | 108.81M | 0.77% | 22,323 | 14.22M |
| 372 | PYPD | PolyPid Ltd. | 107.65M | -1.67% | 15,998 | - |
| 373 | GNLX | Genelux Corporation | 107.55M | -1.64% | 148,169 | 8.00K |
| 374 | ACET | Adicet Bio, Inc. | 106.03M | 2.71% | 26,692 | - |
| 375 | NTHI | NeOnc Technologies Holdings, Inc. | 104.40M | -16.50% | 172,374 | 39.99K |
| 376 | ONCY | Oncolytics Biotech Inc. | 102.01M | -5.12% | 488,612 | - |
| 377 | ANIX | Anixa Biosciences, Inc. | 101.39M | -2.93% | 85,918 | - |
| 378 | RNXT | RenovoRx, Inc. | 101.09M | -6.28% | 449,185 | 1.98M |
| 379 | PLYX | Polaryx Therapeutics, Inc. | 99.19M | -0.50% | 2,207 | - |
| 380 | PMVP | PMV Pharmaceuticals, Inc. | 98.92M | 1.55% | 163,459 | - |
| 381 | CGTX | Cognition Therapeutics, Inc. | 96.52M | -1.46% | 108,368 | - |
| 382 | ACRV | Acrivon Therapeutics, Inc. | 91.67M | 0.43% | 40,161 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 91.50M | -1.85% | 9,522 | 43.30M |
| 384 | KLRS | Kalaris Therapeutics, Inc. | 90.46M | -2.56% | 24,153 | - |
| 385 | VRCA | Verrica Pharmaceuticals Inc. | 90.19M | -0.94% | 43,864 | 30.32M |
| 386 | ICCC | ImmuCell Corporation | 89.87M | -0.05% | 1,777 | 30.68M |
| 387 | RLYB | Rallybio Corporation | 89.38M | -0.56% | 386 | 646.00K |
| 388 | ALDX | Aldeyra Therapeutics, Inc. | 89.28M | - | 77,947 | - |
| 389 | FBIO | Fortress Biotech, Inc. | 89.05M | -1.84% | 60,433 | 68.47M |
| 390 | OSTX | OS Therapies Incorporated | 88.10M | 1.60% | 607,712 | - |
| 391 | GOSS | Gossamer Bio, Inc. | 87.26M | 1.83% | 2,386,109 | 53.29M |
| 392 | CRDF | Cardiff Oncology, Inc. | 87.13M | 2.75% | 408,889 | 508.00K |
| 393 | IBIO | iBio, Inc. | 83.92M | -0.38% | 52,511 | 100.00K |
| 394 | YARW | Yarrow Bioscience, Inc. | 83.80M | -0.93% | 19,325 | - |
| 395 | MNOV | MediciNova, Inc. | 83.68M | 4.29% | 29,739 | 920.48K |
| 396 | OKYO | OKYO Pharma Limited | 82.39M | - | 25,450 | - |
| 397 | GANX | Gain Therapeutics, Inc. | 79.87M | 1.67% | 59,822 | - |
| 398 | TELO | Telomir Pharmaceuticals, Inc. | 79.78M | - | 12,074 | - |
| 399 | MAIA | MAIA Biotechnology, Inc. | 79.68M | -0.76% | 62,100 | - |
| 400 | RNTX | Rein Therapeutics Inc. | 79.40M | 3.52% | 244,106 | - |
| 401 | BSEM | BioStem Technologies, Inc. | 78.54M | 18.60% | 229,616 | 34.59M |
| 402 | DWTX | Dogwood Therapeutics, Inc. | 78.18M | 0.44% | 19,581 | - |
| 403 | ATHE | Alterity Therapeutics Limited | 78.07M | 0.21% | 14,544 | 2.50M |
| 404 | CING | Cingulate Inc. | 74.45M | 0.39% | 13,865 | - |
| 405 | NRXS | NeurAxis, Inc. | 74.09M | -1.01% | 18,941 | 5.32M |
| 406 | CSBR | Champions Oncology, Inc. | 71.14M | -1.92% | 790 | 59.43M |
| 407 | BRTX | BioRestorative Therapies, Inc. | 70.83M | -6.08% | 29,941 | 357.87K |
| 408 | LONA | LeonaBio, Inc. | 70.66M | -0.79% | 3,745 | - |
| 409 | SPRO | Spero Therapeutics, Inc. | 70.17M | -0.41% | 49,598 | 47.00M |
| 410 | PLRX | Pliant Therapeutics, Inc. | 69.97M | -2.59% | 199,450 | - |
| 411 | NTRB | Nutriband Inc. | 69.29M | -4.52% | 34,667 | 1.62M |
| 412 | INMB | INmune Bio Inc. | 68.83M | 1.64% | 139,419 | 50.00K |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 67.97M | 12.27% | 6,675 | - |
| 414 | XBIT | XBiotech Inc. | 66.77M | -0.45% | 20,695 | - |
| 415 | EXOZ | eXoZymes, Inc. | 66.45M | 4.53% | 2,590 | -700.00 |
| 416 | HRTX | Heron Therapeutics, Inc. | 66.45M | 1.77% | 389,476 | 151.18M |
| 417 | SER | Serina Therapeutics, Inc. | 65.66M | -5.31% | 17,757 | 130.00K |
| 418 | BOLD | Boundless Bio, Inc. | 65.28M | - | 140,046 | - |
| 419 | EDSA | Edesa Biotech, Inc. | 64.86M | 1.48% | 1,644 | - |
| 420 | HYFT | MindWalk Holdings Corp. | 63.43M | 2.27% | 40,720 | 11.43M |
| 421 | ELTX | Elicio Therapeutics, Inc. | 62.95M | -0.62% | 93,035 | - |
| 422 | ALPS | Alps Group Inc | 61.58M | -2.61% | 3,247 | 3.74M |
| 423 | XLO | Xilio Therapeutics, Inc. | 60.27M | 1.78% | 1,649 | 64.09M |
| 424 | INKT | MiNK Therapeutics, Inc. | 60.16M | 1.29% | 3,077 | - |
| 425 | ANVS | Annovis Bio, Inc. | 58.80M | -0.72% | 250,276 | - |
| 426 | APLM | Apollomics, Inc. | 58.50M | -3.11% | 3,458 | 8.84M |
| 427 | IMA | ImageneBio, Inc. | 56.76M | 3.09% | 1,773 | 800.00K |
| 428 | MCRB | Seres Therapeutics, Inc. | 56.27M | -1.05% | 4,790 | 1.88M |
| 429 | IBO | Impact BioMedical Inc. | 55.71M | -4.31% | 66,282 | 35.00K |
| 430 | HYPD | Hyperion DeFi, Inc. | 52.06M | 1.52% | 682,619 | 1.40M |
| 431 | TIL | Instil Bio, Inc. | 51.41M | - | 1,631 | - |
| 432 | IMMP | Immutep Limited | 50.00M | - | 34,533 | 13.79M |
| 433 | CELU | Celularity Inc. | 49.35M | 1.49% | 64,012 | 26.55M |
| 434 | ATYR | aTyr Pharma, Inc. | 48.95M | 0.34% | 168,657 | 190.00K |
| 435 | TVGN | Tevogen Inc. | 47.66M | -0.27% | 717 | - |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 47.63M | 1.42% | 228,908 | 21.00M |
| 437 | VERU | Veru Inc. | 46.04M | 2.27% | 652,147 | 16.89M |
| 438 | GRCE | Grace Therapeutics, Inc. | 43.75M | -0.95% | 69,794 | - |
| 439 | MGX | Metagenomi Therapeutics, Inc. | 43.63M | -1.28% | 22,016 | 13.56M |
| 440 | MREO | Mereo BioPharma Group plc | 40.08M | 0.40% | 350,341 | 500.00K |
| 441 | KPTI | Karyopharm Therapeutics Inc. | 39.47M | -2.79% | 197,527 | 146.62M |
| 442 | LITS | Lite Strategy, Inc. | 38.11M | -1.75% | 86,946 | - |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 38.04M | 17.48% | 287,262 | 35.09M |
| 444 | ALGS | Aligos Therapeutics, Inc. | 37.16M | -4.19% | 45,511 | 31.52M |
| 445 | CRVO | CervoMed Inc. | 37.04M | -4.30% | 269,820 | 331.30K |
| 446 | FLNA | Filana Therapeutics, Inc. | 36.61M | -7.58% | 243,297 | - |
| 447 | NXTC | NextCure, Inc. | 36.07M | 0.77% | 9,500 | - |
| 448 | RNAZ | TransCode Therapeutics, Inc. | 34.37M | -1.46% | 10,732 | - |
| 449 | KYNB | Kyntra Bio, Inc. | 34.30M | -0.94% | 4,463 | 4.62M |
| 450 | ACTU | Actuate Therapeutics, Inc. | 33.24M | -6.47% | 107,449 | - |
| 451 | CNTX | Context Therapeutics Inc. | 32.98M | -0.77% | 481,270 | - |
| 452 | QNCX | Quince Therapeutics, Inc. | 31.01M | -2.65% | 1,969 | - |
| 453 | BCTX | BriaCell Therapeutics Corp. | 31.00M | -3.08% | 61,862 | - |
| 454 | BRNS | Barinthus Biotherapeutics plc | 30.94M | -0.20% | 34,986 | 14.97M |
| 455 | IGC | IGC Pharma, Inc. | 30.91M | 0.34% | 111,094 | 1.11M |
| 456 | CVM | CEL-SCI Corporation | 29.90M | 4.29% | 82,993 | - |
| 457 | ESLA | Estrella Immunopharma, Inc. | 28.27M | 0.57% | 20,833 | - |
| 458 | RADX | Radiopharm Theranostics Limited | 28.18M | 1.44% | 4,048 | 9.34M |
| 459 | EVAX | Evaxion A/S | 27.27M | 4.81% | 32,507 | 7.49M |
| 460 | ABVC | ABVC BioPharma, Inc. | 25.48M | 2.38% | 28,152 | 797.92K |
| 461 | QNTM | Quantum BioPharma Ltd. | 25.48M | -2.78% | 55,467 | - |
| 462 | ATOS | Atossa Therapeutics, Inc. | 25.45M | 1.19% | 10,900 | - |
| 463 | BYSI | BeyondSpring Inc. | 25.42M | - | 9,594 | 1.88M |
| 464 | TVRD | Tvardi Therapeutics, Inc. | 25.34M | -0.52% | 51,517 | - |
| 465 | NNVC | NanoViricides, Inc. | 25.29M | -0.89% | 98,128 | - |
| 466 | TCRX | TScan Therapeutics, Inc. | 24.52M | -7.61% | 415,808 | 7.11M |
| 467 | JSPR | Jasper Therapeutics, Inc. | 24.26M | 2.88% | 63,892 | - |
| 468 | LTRN | Lantern Pharma Inc. | 24.03M | -1.31% | 29,005 | - |
| 469 | GRDX | GridAI Technologies Corp. | 23.58M | 2.46% | 10,005 | - |
| 470 | AKTX | Akari Therapeutics, Plc | 23.32M | 4.45% | 22,235 | - |
| 471 | CLRB | Cellectar Biosciences, Inc. | 22.97M | 2.53% | 1,966 | - |
| 472 | GNTA | Genenta Science S.p.A. | 22.88M | 1.03% | 16,238 | - |
| 473 | COCP | Cocrystal Pharma, Inc. | 22.73M | 4.42% | 30,021 | 330.00K |
| 474 | PTN | Palatin Technologies, Inc. | 22.68M | 1.18% | 5,885 | 12.88M |
| 475 | LGVN | Longeveron Inc. | 21.27M | -2.06% | 11,992 | 1.19M |
| 476 | MRKR | Marker Therapeutics, Inc. | 21.01M | 6.78% | 38,784 | 3.55M |
| 477 | ALLR | Allarity Therapeutics, Inc. | 20.84M | -7.75% | 62,738 | 345.00K |
| 478 | PLRZ | Polyrizon Ltd. | 20.81M | -1.11% | 2,151 | - |
| 479 | CMMB | Chemomab Therapeutics Ltd. | 20.65M | 5.17% | 38,805 | - |
| 480 | NEUP | Neuphoria Therapeutics Inc. | 20.54M | 0.80% | 2,163 | -13.27K |
| 481 | KTTA | Pasithea Therapeutics Corp. | 19.89M | 2.64% | 32,620 | - |
| 482 | CNSY | Cerenome, Inc. | 19.73M | -5.63% | 22,164 | 4.20M |
| 483 | DYAI | Dyadic International, Inc. | 19.49M | 2.85% | 43,927 | 3.80M |
| 484 | LPCN | Lipocine Inc. | 19.46M | -3.67% | 6,111 | 1.57M |
| 485 | NCEL | NewcelX Ltd. | 19.35M | - | 105 | - |
| 486 | ENLV | Enlivex Ltd. | 18.88M | -1.82% | 44,173 | - |
| 487 | NIKI | Niki BioSolutions, Inc. | 18.81M | 3.23% | 48,279 | - |
| 488 | NRSN | NeuroSense Therapeutics Ltd. | 18.68M | -1.08% | 326,466 | - |
| 489 | PDSB | PDS Biotechnology Corporation | 18.51M | 50.32% | 341,392,792 | - |
| 490 | ADIL | Adial Pharmaceuticals, Inc. | 17.62M | -5.76% | 16,810 | - |
| 491 | PBM | Psyence Biomedical Ltd. | 17.36M | 0.22% | 10,354 | - |
| 492 | BCDA | BioCardia, Inc. | 16.80M | 2.78% | 26,509 | 3.00K |
| 493 | BIVI | BioVie Inc. | 16.07M | 6.50% | 135,216 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 16.02M | -0.73% | 75,393 | 7.11M |
| 495 | PASG | Passage Bio, Inc. | 15.86M | 6.02% | 3,752 | - |
| 496 | TPST | Tempest Therapeutics, Inc. | 15.82M | -3.88% | 75,601 | - |
| 497 | LSTA | Lisata Therapeutics, Inc. | 15.25M | 2.56% | 35,793 | 100.00K |
| 498 | LEXX | Lexaria Bioscience Corp. | 15.20M | -34.98% | 45,115 | 194.00K |
| 499 | PLUR | Pluri Inc. | 14.89M | 1.47% | 1,541 | 1.08M |
| 500 | MBRX | Moleculin Biotech, Inc. | 14.71M | 6.35% | 356,386 | - |